Paul Howes
Direktor/Vorstandsmitglied bei KISH BANCORP, INC.
Profil
Paul G.
Howes is currently the Vice Chairman at Kish Bancorp, Inc. He is also a Director at the National Society to Prevent Blindness and Kish Bank.
Previously, he served as the President, Chief Executive Officer & Director at Inotek Pharmaceuticals Corp.
from 2008 to 2013.
He was also the President & Chief Executive Officer at DuPont Merck Pharmaceutical Co. Additionally, he held the position of Executive Chairman & President at Thrombogenics, Inc. from 2014 to 2017.
From 2013 to 2018, he served as a Non-Executive Director at Oxurion NV.
He was a Director at BioNJ, Inc. and President-Americas Region at Bausch & Lomb, Inc. from 2003 to 2007.
Prior to that, he was the Vice President-Mid Atlantic Business Group at Merck & Co., Inc. from 1998 to 2003.
He also worked as a Principal at PricewaterhouseCoopers Canada and President at Merck Frosst Canada Ltd.
He is a Member of The Canadian Institute of Chartered Accountants.
Mr. Howes holds an MBA degree from York University and an undergraduate degree from Harvard College.
Aktive Positionen von Paul Howes
| Unternehmen | Position | Beginn |
|---|---|---|
| KISH BANCORP, INC. | Direktor/Vorstandsmitglied | - |
National Society to Prevent Blindness
 National Society to Prevent Blindness Miscellaneous Commercial ServicesCommercial Services National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL. | Direktor/Vorstandsmitglied | - |
Kish Bank
 Kish Bank Regional BanksFinance Kish Bank provides banking services. It offers personal banking, business banking, wealth management, and professional services. The company was founded in 1935 and is headquartered in 1900 and is headquartered in Belleville, PA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Paul Howes
| Unternehmen | Position | Ende |
|---|---|---|
| OXURION NV | Direktor/Vorstandsmitglied | 29.10.2018 |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Vorsitzender | 01.01.2017 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Corporate Officer/Principal | 01.01.2007 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.06.2003 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direktor/Vorstandsmitglied | - |
Ausbildung von Paul Howes
| York University | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KISH BANCORP, INC. | Finance |
| OXURION NV | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Health Technology |
National Society to Prevent Blindness
National Society to Prevent Blindness Miscellaneous Commercial ServicesCommercial Services National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL. | Commercial Services |
PricewaterhouseCoopers Canada
 PricewaterhouseCoopers Canada Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers Canada provides accounting services. The private company is based in Toronto, Canada. | Commercial Services |
Kish Bank
Kish Bank Regional BanksFinance Kish Bank provides banking services. It offers personal banking, business banking, wealth management, and professional services. The company was founded in 1935 and is headquartered in 1900 and is headquartered in Belleville, PA. | Finance |
The Canadian Institute of Chartered Accountants
 The Canadian Institute of Chartered Accountants Miscellaneous Commercial ServicesCommercial Services Canadian Institute of Chartered Accountants engages in the provision of accounting, auditing, tax, advisory, and professional services. The institute is headquartered in Toronto, Canada. | Commercial Services |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Commercial Services |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
